Trial Profile
Pharmacogenetics and Therapeutic Drug Monitoring for the Optimization of Fluoropyrimidine Treatment in Patients With Advanced Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Fluorouracil
- Indications Colorectal cancer
- Focus Adverse reactions; Pharmacogenomic
- Acronyms FLOXTOX2
- 01 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jul 2012 New trial record